Literature DB >> 2192878

Dyslipoproteinemia and diabetes.

T J Orchard1.   

Abstract

Lipoprotein changes in diabetes are discussed from both a pathophysiologic and clinical viewpoint. Though differences in concentrations are often small and vary according to the type of diabetes, other changes in lipoprotein metabolism are presented. The interrelationships between diabetes, insulin, and heart disease are also discussed, with the central role of insulin being stressed. Finally, the clinical management of lipid disorders in diabetes is addressed.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2192878

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  15 in total

1.  Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).

Authors:  Rachel G Miller; Tina Costacou; Trevor J Orchard
Journal:  Diabetes       Date:  2018-11-08       Impact factor: 9.461

2.  Modifications of coronary risk factors.

Authors:  Jeanine Albu; Sheldon H Gottlieb; Phyllis August; Richard W Nesto; Trevor J Orchard
Journal:  Am J Cardiol       Date:  2006-04-19       Impact factor: 2.778

3.  Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.

Authors:  Tina Costacou; Andrew P Levy; Rachel G Miller; Janet Snell-Bergeon; Rabea Asleh; Dan Farbstein; Catherine E Fickley; Georgia Pambianco; Rona de la Vega; Rhobert W Evans; Trevor J Orchard
Journal:  Acta Diabetol       Date:  2015-05-24       Impact factor: 4.280

4.  Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study.

Authors:  E Koukkou; G F Watts; C Lowy
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

Review 5.  Haptoglobin genotype and its role in diabetic cardiovascular disease.

Authors:  Tina Costacou; Andrew P Levy
Journal:  J Cardiovasc Transl Res       Date:  2012-03-24       Impact factor: 4.132

6.  High-density lipoprotein cholesterol in diabetes: is higher always better?

Authors:  Tina Costacou; Rhobert W Evans; Trevor J Orchard
Journal:  J Clin Lipidol       Date:  2011-06-28       Impact factor: 4.766

7.  The effect of Gongronema latifolium extracts on serum lipid profile and oxidative stress in hepatocytes of diabetic rats.

Authors:  N H Ugochukwu; N E Babady; M Cobourne; S R Gasset
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

Review 8.  An Obesity Paradox: Increased Body Mass Index Is Associated with Decreased Aortic Atherosclerosis.

Authors:  Rolf F Barth; L Maximilian Buja; Lei Cao; Sergey V Brodsky
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

9.  The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study.

Authors:  Kelly J Hunt; Ken Williams; Helen P Hazuda; Michael P Stern; Steve M Haffner
Journal:  Ann Epidemiol       Date:  2007-07-27       Impact factor: 3.797

Review 10.  Is there a paradox in obesity?

Authors:  Akankasha Goyal; Kameswara Rao Nimmakayala; Joel Zonszein
Journal:  Cardiol Rev       Date:  2014 Jul-Aug       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.